Modelling prognostic factors in advanced pancreatic cancer.

Modelling prognostic factors in advanced pancreatic cancer.

Pancreatic cancer is the fifth most common cause of cancer death. Identification of defined patient groups based on a prognostic index may improve the prediction of survival and selection of therapy. Many prognostic factors have been identified often based on retrospective, underpowered studies with...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Stocken, D, Hassan, A, Altman, D, Billingham, L, Bramhall, SR, Johnson, P, Freemantle, N
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2008

Míreanna comhchosúla

Choice of transformation for modelling non-linear continuous biomarkers
de réir: Stocken Deborah D, et al.
Foilsithe / Cruthaithe: (2011-12-01)

A phase II irinotecan-cisplatin combination in advanced pancreatic cancer.
de réir: Markham, C, et al.
Foilsithe / Cruthaithe: (2003)

Acute pancreatitis: current perspectives on diagnosis and management
de réir: Shah AP, et al.
Foilsithe / Cruthaithe: (2018-03-01)

Prognostic models: a methodological framework and review of models for breast cancer.
de réir: Altman, D
Foilsithe / Cruthaithe: (2009)

Advancing Prognostication in Pancreatic Cancer: A Comprehensive Cohort Analysis
de réir: Shikhar Tripathi, et al.
Foilsithe / Cruthaithe: (2024-09-01)

Locally Advanced and Metastatic Pancreatic Cancer: Survival analysis and prognostic factors in a case series
de réir: Paloma Porto Amorim, et al.
Foilsithe / Cruthaithe: (2020-01-01)

Prognostic Factors for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Receiving Neoadjuvant FOLFIRINOX
de réir: Young Hoon Choi, et al.
Foilsithe / Cruthaithe: (2021-03-01)

Sample Size Calculations for Designing Clinical Proteomic Profiling Studies Using Mass Spectrometry
de réir: Nyangoma, S, et al.
Foilsithe / Cruthaithe: (2012)

Modeling Prognostic Factors in Resectable Pancreatic Adenocarcinomas
de réir: Taxiarchis Botsis, et al.
Foilsithe / Cruthaithe: (2010-01-01)

Modeling Prognostic Factors in Resectable Pancreatic Adenocarcinomas
de réir: Taxiarchis Botsis, et al.
Foilsithe / Cruthaithe: (2009-01-01)

Identification of clinically useful cancer prognostic factors: what are we missing?
de réir: McShane, L, et al.
Foilsithe / Cruthaithe: (2005)

Exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy
de réir: Yue Ma, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Reporting performance of prognostic models in cancer: a review.
de réir: Mallett, S, et al.
Foilsithe / Cruthaithe: (2010)

A prognostic model for ovarian cancer.
de réir: Clark, T, et al.
Foilsithe / Cruthaithe: (2001)

Clinicodemographic aspect of resectable pancreatic cancer and prognostic factors for resectable cancer
de réir: Chiang Kun-Chun, et al.
Foilsithe / Cruthaithe: (2012-05-01)

Comment on ‘exploring prognostic factors for survival in patients with advanced pancreatic cancer undergoing PD-1 inhibitor immunotherapy’
de réir: Jiaqing Wang, et al.
Foilsithe / Cruthaithe: (2024-12-01)

Developing a prognostic model in the presence of missing data: an ovarian cancer case study.
de réir: Clark, T, et al.
Foilsithe / Cruthaithe: (2003)

Reporting methods in studies developing prognostic models in cancer: a review.
de réir: Mallett, S, et al.
Foilsithe / Cruthaithe: (2010)

Prognosis and prognostic research: Developing a prognostic model
de réir: Royston, P, et al.
Foilsithe / Cruthaithe: (2009)

Prognosis and prognostic research: validating a prognostic model.
de réir: Altman, D, et al.
Foilsithe / Cruthaithe: (2009)

Prognosis and prognostic research: Developing a prognostic model.
de réir: Royston, P, et al.
Foilsithe / Cruthaithe: (2009)

Prognosis and prognostic research: Validating a prognostic model
de réir: Altman, D, et al.
Foilsithe / Cruthaithe: (2009)

Prognosis and prognostic research: validating a prognostic model.
de réir: Altman, D, et al.
Foilsithe / Cruthaithe: (2009)

Pancreatic neuroendocrine tumors: prognostic factors
de réir: Javier A. Cienfuegos, et al.

The Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio Are Prognostic Factors in Patients with Locally Advanced Pancreatic Cancer Treated with Chemoradiotherapy
de réir: Byung Min Lee, et al.
Foilsithe / Cruthaithe: (2018-05-01)

Retrospective Cohort Study of Caveolin-1 Expression as Prognostic Factor in Unresectable Locally Advanced or Metastatic Pancreatic Cancer Patients
de réir: Alessandro Bittoni, et al.
Foilsithe / Cruthaithe: (2021-09-01)

Inflammatory Parameters as Available Prognostic Factors for Pancreatic Cancer after Chemoradiotherapy
de réir: Chang Min Cho
Foilsithe / Cruthaithe: (2018-05-01)

Identification of prognostic risk factors for pancreatic cancer using bioinformatics analysis
de réir: Dandan Jin, et al.
Foilsithe / Cruthaithe: (2020-06-01)

A prognostic model for anoikis-related genes in pancreatic cancer
de réir: Wenbin Song, et al.
Foilsithe / Cruthaithe: (2024-07-01)

Effects of anoxic prognostic model on immune microenvironment in pancreatic cancer
de réir: Yangdong Wu, et al.
Foilsithe / Cruthaithe: (2023-06-01)

External validation of the prognostic relevance of the advanced lung cancer inflammation index (ALI) in pancreatic cancer patients
de réir: Dominik Andreas Barth, et al.
Foilsithe / Cruthaithe: (2020-08-01)

Prediction and identification of synergistic compound combinations against pancreatic cancer cells
de réir: Yasaman KalantarMotamedi, et al.
Foilsithe / Cruthaithe: (2021-09-01)

Prognosis and prognostic research: application and impact of prognostic models in clinical practice.
de réir: Moons, K, et al.
Foilsithe / Cruthaithe: (2009)

Phase II Trial of Erlotinib Plus Gemcitabine Chemotherapy in Korean Patients with Advanced Pancreatic Cancer and Prognostic Factors for Chemotherapeutic Response
Foilsithe / Cruthaithe: (2013-09-01)

Recent Advances in Pancreatic Cancer: Novel Prognostic Biomarkers and Targeted Therapy—A Review of the Literature
de réir: Konstantin Schlick, et al.
Foilsithe / Cruthaithe: (2021-10-01)

External validation of a Cox prognostic model: principles and methods.
de réir: Royston, P, et al.
Foilsithe / Cruthaithe: (2013)

What do we mean by validating a prognostic model?
de réir: Altman, D, et al.
Foilsithe / Cruthaithe: (2000)

Sarcopenia as a Prognostic Factor of Hepatotoxicity and Lower Survival Rate in Chemotherapy of Pancreatic Cancer
de réir: A. A. Klunichenko, et al.
Foilsithe / Cruthaithe: (2020-07-01)

Anti-tumour efficacy of capecitabine in a genetically engineered mouse model of pancreatic cancer.
de réir: Aurélie Courtin, et al.
Foilsithe / Cruthaithe: (2013-01-01)

Prognostic Usefulness Of Advanced Lung Cancer Inflammation Index In Locally-Advanced Pancreatic Carcinoma Patients Treated With Radical Chemoradiotherapy
de réir: Topkan E, et al.
Foilsithe / Cruthaithe: (2019-10-01)